| 000 | 01070nas a2200361 a 4500 | ||
|---|---|---|---|
| 001 | vtls000052264 | ||
| 003 | UG-KaMUL | ||
| 005 | 20250608175952.0 | ||
| 008 | 050520c19929999xxkmr1 0 0eng d | ||
| 022 | _a10538569 | ||
| 039 |
_a200812191039 _b909 _y200505201610 _z919 |
||
| 040 | _aUG-KaMUL | ||
| 060 |
_aPER W1 _bPH272Q |
||
| 210 | _aPharmacoepidemiol Drug Saf | ||
| 222 | _aPharmacoepidemiology and drug safety | ||
| 245 | 0 | _aPharmacoepidemiology and drug safety. | |
| 260 |
_aChichester, West Sussex : _bWiley, _c1992- |
||
| 300 |
_av. ; _c30 cm. |
||
| 310 |
_aTwelve no. a year, _b2004- |
||
| 321 |
_aFrequency varies, _b-2003 |
||
| 362 | 1 | _av. 1, no. 1 (Jan.-Feb. 1992)- | |
| 500 | _aTitle from cover. | ||
| 530 | _aAlso available online. | ||
| 650 |
_aDrug Therapy _xadverse effects. |
||
| 650 | _aDrug utilization. | ||
| 650 | _aEpidemiologic methods. | ||
| 650 | _aEpidemiology. | ||
| 650 | _aPharmacology, clinical. | ||
| 850 | _cPER | ||
| 942 |
_2ddc _cBK |
||
| 999 |
_c61486 _d61486 |
||